Podcast 34: Parenteral Drugs: CDMOs/CMOs Expanding
By

By
Parenteral drugs have accounted for between 40% and 50% of new drug approvals over the past five years. CDMOs/CMOs continue to expand. Key topics: (see Chapter Markers in drop down…

Podcast 33: Rising Energy Costs and API Supply
By

By
Escalating energy prices are impacting global manufacturing and supply chains. In the EU, leaders are proposing measures to alleviate energy pricing pressures. What’s the plan in the EU and the…

Podcast 32: Blockbuster Muscle: Small Molecules or Biologics?
By

By
Which modality, small molecules or biologics, leads among the top-selling products? A look at the top-selling products industry-wide and blockbusters from select leading bio/pharma companies provides the answer. For the…

Podcast 31: Injectable and Solid Dosage Drug Delivery: Key Deals
By

By
Drug delivery is important not only for ensuring bioavailability for therapeutic benefit but also for product differentiation and market success. DCAT Value Chain Insights highlights technology advances in drug delivery for injectable…

Podcast 30: Mid-Year CDMO Review: COVID-19 Vaccine Manufacturing and M&A
By

By
What have been the key developments in 2021 thus far in the CDMO market? In this podcast we take a look at the increasing participation by CDMOs in COVID-19 vaccine…

Podcast 29: FDA Addresses Supply Constraints Due to COVID-19; Plus, Packaging Suppliers Expand
By

By
In this podcast we take a look at the FDA’s new guidance to facilitate changes to container-closure-system components due to supply constraints, plus updates from suppliers of materials used to…

Podcast 28: The Year in Review: 2020
By

By
Although the COVID-19 pandemic dominated the headlines in 2020, there were other key developments in 2020. In this year in review, we look at the other key developments in 2020,…

Podcast 27: Company on the Move: Viatris
By

By
In this podcast we feature an article about what and who is behind Viatris, the new company formed from the combination of Upjohn, Pfizer’s off-patent branded and generic established medicines…

Podcast 26: Solid-Dosage Mfg: CDMO Market and Product Trends
By

By
In this podcast we feature an article that looks at solid dosage manufacturing in terms of CDMO growth rates and recent product trends. For the text version of this article…

Podcast 25: Top 10 Watch List: Pharma CEOs on the Rise
By

By
In this podcast we feature a list of the Top 10 pharma CEOs to watch in 2020. Key topics: (see Chapter Markers) Pharma CEOs to watch in 2020 1. Three-way…